Tissue factor on cells

Blood Coagulation and Fibrinolysis

Volumn 9, Issue SUPPL. 1, 1998, Pages

  Rao, L V M ^a   Pendurthi, U R ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Anionic phospholipid; Antithrombin; Cells; Coagulation; Factor VII; Thrombosis; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BASIC FIBROBLAST GROWTH FACTOR; BLOOD CLOTTING FACTOR 7; ENDOTOXIN; GLYCOPROTEIN; GROWTH FACTOR; HEPARAN SULFATE; INTERLEUKIN 1; NEUTRALIZING ANTIBODY; PHOSPHOLIPID; THROMBOPLASTIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

BLEEDING; BLOOD CLOTTING; CATALYSIS; CELL MEMBRANE; CELL SURFACE; CONFERENCE PAPER; GENE EXPRESSION; HEMOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; ONCOGENE C FOS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOSIS; TISSUE INJURY; TRANSCRIPTION REGULATION;

CELL MEMBRANE; FACTOR VIIA; HUMANS; THROMBOPLASTIN; TRANSCRIPTION, GENETIC;

EID: 0031728405     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (82)

1. Rapaport SI, Rao LVM. The tissue factor pathway: how it has become a 'prima ballerina'. Thromb Haemost 1995; 74:7-17.
2. Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost 1997; 78:759-764.
3. Østerud B. Tissue factor: a complex biological role. Thromb Haemost 1997; 78:755-758.
4. Bugge TH, Xiao Q, Kombrinck KW, Flick MJ, Holmback K, Danton MJS, et al. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996; 93:6258-6263.
5. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88:1583-1587.
6. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, van Vlaenderen I, et al. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383:73-75.
7. Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81:1-41.
8. Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol 1996; 3:379-384.
9. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134:1087-1097.
10. Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 59:421-437.
11. Østerud B. Cellular interactions in tissue factor expression by blood monocytes. Blood Coagul Fibronolysis 1995; 6:S20-S25.
12. Drake TA, Cheng J, Chang A, Taylor FB Jr. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Patrol 1993; 142:1458-1470.
13. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature Med 1996; 2:209-215.
14. Zhang Y, Deng Y, Wendt T, Liliensiek B, Bierhaus A, Greten J, et al. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced expression and fibrin deposition in mouse Meth-A sarcomas. J Clin Invest 1996; 97:2213-2214.
15. Warr TA, Rao LVM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75:1481-1489.
16. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw LB, Catlett R, et al. Lethal E.coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33:127-134.
17. Taubman MB, Fallon JT, Schecter AD, Giesen P, Mendlowitz M, Fyfe BS, et al. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 1997; 78:200-204.
18. Mackman N. Regulation of tissue factor gene. Thromb Haemost 1997; 78:747-754.
19. Thanos D, Maniatis T. NF-κB: a lesson in family values. Cell 1995; 80:529-532.
20. Ramani M, Ollivier V, Ternisien C, Vu T, Elbim C, Hakim J, de Prost D. Interleukin 4 prevents the induction of tissue factor mRNA in human monocytes in response to LPS or PMA stimulation. Br J Haematol 1993; 85:462-468.
21. Ramani M, Ollivier V, Khechai F, Vu T, Ternisien C, Bridey F, de Prost D. Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes. FEBS Lett 1993; 334:114-116.
22. Jungi TW, Brcic M, Eperon S, Albrecht S. Transforming growth factor-beta and interleukin-10, but not interleukin-4, down-regulate procoagulant activity and tissue factor expression in human monocyte-derived macrophages. Thromb Res 1994; 76:463-474.
23. Ernofsson M, Tenno T, Siegbahna A. Inhibition of tissue factor surface expression in human peripheral blood. Br J Haematol 1996; 95:249-257.
24. Ishii H, Horie S, Kizaki K, Kazama M. Retinoic acid counteracts both the down-regulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood 1992; 80:2556-2562.
25. Barstad RM, Hamers MJAG, Stephens RW, Sakariassen KS. Retinoic acid reduces induction of monocyte tissue factor and tissue factor/factor VIIa-dependent arterial thrombus formation. Blood 1995; 86:212-218.
26. Koyama T, Hirosawa S, Kawamata N, Tohda S, Aoki N. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells. Blood 1994; 84:3001-3009.
27. de Prost D, Ollivier V, Hakim J. Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear phagocytes. Mol Pharmacol 1990; 38:562-566.
28. Crutchley DJ, Solomon DE, Conanan LB. Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism. Arterioscler Thromb 1992; 12:664-670.
29. Crutchley DJ, Conanan LB, Toledo AW, Solomon DE, Que BG. Effects of prostacyclin analogues on human endothelial cell tissue factor expression. Arterioscler Thromb 1993; 13:1082-1089.
30. Ollivier V, Houssaye S, Ternisien C, Leon A, DeVerneuil H, Mackman N, et al. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood 1993; 81:973-979.
31. Ollivier V, Parry GCN, Cobb RR, deProst D, Mackman N. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 1996; 271:20828-20835.
32. Almus FE, Rao LVM, Rapaport SI. Decreased inducibility of tissue factor activity on human umbilical vein endothelial cells cultured with endothelial cell growth factor and heparin. Thromb Res 1988; 50:339-344.
33. Almus FE, Rao LVM, Pendurthi UR, Quattrochi L, Rapaport SI. Mechanism for diminished tissue factor expression by endothelial cells cultured with heparin binding growth factor-1 and heparin. Blood 1991; 77:1256-1262.
34. Pendurthi UR, Williams JT, Rao LVM. Acidic and basic fibroblast growth factors suppress transcriptional activation of tissue factor and other inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol 1997; 17:940-946.
35. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994;79:185-188.
36. Huang Q, Neuenschwander PF, Rezaie AR, Morrissey JH. Substrate recognition by tissue factor-factor VIIa. J Biol Chem 1996; 271:21752-21757.
37. Rao LVM, Robinson T, Hoang AD. Factor VIIa/tissue factor-catalyzed activation of factors IX and X on a cell surface and in suspension: a kinetic study. Thromb Haemost 1992; 67:654-659.
38. Le DT, Rapaport SI, Rao LVM. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem 1992; 267:15447-15454.
39. Bach R, Rifkin DB. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci USA 1990; 87:6995-6999.
40. Carson SD, Perry GA, Pirruccello SJ. Fibroblast tissue factor: calcium and ionophore induce shape changes, release of membrane vesicles, and redistribution of tissue factor antigen in addition to increased procoagulant activity. Blood 1994; 84:526-534.
41. Le DT, Rapaport SI, Rao LVM. Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X in fibroblast monolayers after their exposure to N-ethylmaleimide. Thromb Haemost 1994; 72:848-855.
42. Greeno EW, Bach RR, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 1996; 75:281-286.
43. Bombeli T, Karsan A, Tait J, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89:2429-2442.
44. Kondo S, Noguchi M, Funakoshi T, Fujikawa K, Kisiel W. Inhibition of human factor VIIa-tissue factor activity by placental anticoagulant protein. Thromb Res 1987; 48:449-459.
45. Gramzinski RA, Broze GJ Jr, Carson SD. Human fibroblast tissue factor is inhibited by lipoprotein-associated coagulation inhibitor and placental anticoagulant protein but not by apoprotein A-II. Blood 1989; 73:983-989.
46. Rao LVM, Tait JF, Hoang AD. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb Res 1992; 67:517-531.
47. Rao LVM. Tissue factor activity increase in fibroblasts treated with calcium ionophore is primarily due to formation of microvesides [abstract]. FASEB J 1994; 8: A1374.
48. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89:1121-1132.
49. Bouchard BA, Shatos MA, Tracy PB. Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation. Arterioscler Thromb Vasc Biol 1997; 17:1-9.
50. Carson SD. Manifestation of cryptic fibroblast tissue factor occurs at detergent concentrations which dissolve the plasma membrane. Blood Coag Fibrinol 1996; 7:303-313.
51. Carson SD, Kuszynski CA, Pirruccello SJ. Fibroblasts restrict tissue factor from vesicles which form in response to low concentrations of detergent. Blood Coag Fibrinol 1996; 7:314-324.
52. Camerer E, Pringle S, Skartlien AH, Wiiger M, Prydz K, Kolsto A, Prydz H. Opposite sorting of tissue factor in human umbilical vein endothelial cells and madin-darby canine kidney epithelial cells. Blood 1996; 88:1339-1349.
53. Mulder AB, Smit JW, Bom VJJ, Blom NR, Ruiters MHJ, Halie R, van der Meer J. Association of smooth muscle cell tissue factor with caveolae. Blood 1996; 88:1306-1313.
54. Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood 1997; 89:3270-3276.
55. Broze GJ Jr, Girard TJ, Novotny WE Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29:7539-7545.
56. Rapaport SI. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Thromb Haemost 1991; 66:6-15.
57. Shigematsu Y, Miyata T, Higashi S, Miki T, Sadler JE, Iwanaga S. Expression of human soluble tissue factor in yeast and enzymatic properties of its complex with factor VIIa. J Biol Chem 1992; 267:21329-21337.
58. Lawson JH, Butenas S, Ribarik N, Mann KG. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem 1993; 268:767-770.
59. Rao LVM, Rapaport SI, Hoang AD. Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa. Blood 1993; 81:2600-2607.
60. Sandset PM, Warn-Cramer BJ, Rao LVM, Maki SL, Rapaport SI. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci USA 1991; 88:708-712.
61. Broze GJ Jr, Likert K, Higuchi D. Inhibition of factor VIIa/ tissue factor by antithrombin III and tissue factor pathway inhibitor. Blood 1993; 82:1679-1680.
62. Rao LVM, Nordfang O, Hoang AD, Pendurthi UR. Mechanism of antithrombin III inhibition of VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa induced inhibition of factor VIIa/tissue factor activity. Blood 1995; 85:121-129.
63. Ruf W, Miles DJ, Rehemtulla A, Edgington TS. Tissue factor residues 157-167 are required for efficient proteolytic activation of factor X and factor VIIa. J Biol Chem 1992; 267:22206-22210.
64. Roy S, Hass PE, Bourell JH, Henzel WJ, Vehar GA. Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. J Biol Chem 1991; 266:22063-22066.
65. Ruf W, Miles DJ, Rehemtulla A, Edgington TS. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease. J Biol Chem 1992; 267:6375-6381.
66. Huang X, Molema G, King S, Watkins L, Edgington TS, Thorpe PE. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 1996; 275:547-550.
67. Rao LVM, Ruf W. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of quaternary complex of tissue factor VIIa with Xa tissue factor pathway inhibitor. Biochemistry 1995; 34:10867-10871.
68. Rao LVM, Williams T, Rapaport SI. Studies of activation of factor VII bound to tissue factor. Blood 1996; 87:3738-3748.
69. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991; 30:10819-10824.
70. Hamamoto T, Yamamoto M, Nordfang O, Petersen JGL, Foster DC, Kisiel W. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces. J Biol Chem 1993; 268:8704-8710.
71. Bombeli T, Mueller M, Haeberil A. Anticoagulant properties of the vascular endothelium. Thromb Haemost 1997; 77:408-423.
72. Rosenberg RD, Showorak NW, Liu J, Schwartz JJ, Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest 1997; 99:2062-2070.
73. Hamamoto T, Kisiel W. The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor. Blood Coag Fibrinol 1996; 7:470-476.
74. Schwartz AL. Receptor-cell biology: receptor-mediated endocytosis. Pediatr Res 1995; 38:835-843.
75. Maruyama I, Majerus PW. The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. J Biol Chem 1985; 260:15432-15438.
76. Maruyama I, Majerus PW. Protein C inhibits endocytosis of thrombin-thrombomodulin complexes in A549 lung cancer cells and human umbilical vein endothelial cells.Blood 1987; 69:1481-1484.
77. Fair DS, MacDonald MJ. Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem 1987; 262:11692-11698.
78. Broze GJ Jr. Binding of human factor VII and VIIa to monocytes. J Clin Invest 1982; 70:526-535.
79. Sakai T, Lund-Hansen T, Paborsky L, Pedersen AH, Kisiel W. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). J Biol Chem 1989; 264:9980-9988.
80. Ploplis VA, Edgington TS, Fair DS. Initiation of the extrinsic pathway of coagulation. Association of factor VIIa with a cell line expressing tissue factor. J Biol Chem 1987; 262:9503-9508.
81. Sevinsky JR, Rao LVM, Ruf W. Ligand induced protease receptor translocation into caveolae: a mechanism regulating cell surface proteolysis of the tissue factor dependent coagulation pathway. J Cell Biol 1996; 133:293-304.
82. Ott I, Rao LVM, Ruf W. GPI-anchoring of tissue factor pathway inhibitor is sufficient for targeting to low density detergent insoluble microdomains [abstract]. Circulation 1997; 96 (suppl):I-43.